Anthony Kong

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

S. Chan, A. Urruticoechea, T. Pluard, 2018, Breast Cancer Research and Treatment.